Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.88 +0.03 (+3.41%)
At close: Aug 21, 2026 · 4:00 PM EDT

Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026)

Rani Therapeutics Holdings (RANI) posted quarterly Change in Acquisitions & Divestments of $21.0 million for Q1 2026, little changed year-over-year from $21.0 million in Q1 2025, and up 265.22% quarter-over-quarter from $5.8 million in Q2 2025.

Rani Therapeutics Holdings (RANI) Change in Acquisitions & Divestments (2022 - 2026) Analysis & Trends

Rani Therapeutics Holdings' Change in Acquisitions & Divestments history runs 5 years deep, the most recent figure standing at $21.0 million for Q1 2026.

  • In Q1 2026, Change in Acquisitions & Divestments changed 0.0% year-over-year to $21.0 million; the TTM figure through Mar 2026 stood at $26.8 million (down 65.79% YoY), while the FY2025 annual figure was $26.8 million, down 65.51% from the prior year.
  • Change in Acquisitions & Divestments for Q1 2026 stood at $21.0 million, up from $5.8 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $35.0 million in Q2 2023, with the low at $3.0 million in Q4 2022.
  • The 5-year median for Change in Acquisitions & Divestments is $20.7 million (2024), against an average of $19.4 million.
  • The sharpest annual moves came in 2023 and 2025: Change in Acquisitions & Divestments jumped 661.67% in 2023, then sank 68.41% in 2025.
  • Rani Therapeutics Holdings' Change in Acquisitions & Divestments stood at $3.0 million in 2022, then surged by 661.67% to $22.8 million in 2023, then retreated by 11.16% to $20.3 million in 2024, then sank by 71.67% to $5.8 million in 2025, then soared by 265.22% to $21.0 million in 2026.
  • Business Quant data shows RANI's Change in Acquisitions & Divestments at $21.0 million in Q1 2026, $5.8 million in Q2 2025, and $21.0 million in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 Rani Therapeutics Holdings 163.98 Mn 163.98 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 19.95 Mn
Jun 30, 2026 19.95 Mn
Mar 31, 2026 21.00 Mn
Mar 31, 2026 21.00 Mn
Jun 30, 2025 5.75 Mn
Jun 30, 2025 5.75 Mn
Mar 31, 2025 21.00 Mn
Mar 31, 2025 21.00 Mn
Dec 31, 2024 20.30 Mn
Dec 31, 2024 20.30 Mn
Sep 30, 2024 18.70 Mn
Sep 30, 2024 18.70 Mn
Jun 30, 2024 18.20 Mn
Jun 30, 2024 18.20 Mn
Mar 31, 2024 20.35 Mn
Mar 31, 2024 20.35 Mn
Dec 31, 2023 22.85 Mn
Dec 31, 2023 22.85 Mn
Sep 30, 2023 23.50 Mn
Sep 30, 2023 23.50 Mn